Barry Bannister, Stifel chief equity strategist, joins 'The Exchange' to discuss the markets, his bearish take on risks in ...

Vistagen Therapeutics, Inc. (NASDAQ:VTGN) is among the best growth stocks to invest in for the next 5 years. Analysts at ...

Stifel warns of a 12% decline in the S&P 500 index in the back half of 2025. Its strategist Barry Bannister explained why in ...

Bloomberg journalists discuss today's biggest winners and losers in the stock market. Listen for analysis on the companies making news on Wall Street.

Stifel analyst Ruben Roy last night downgraded CoreWeave (CRWV) to Hold from Buy with a price target of $115, up from $75. While positive on the ...

Equity Residential (NYSE:EQR) is one of the most undervalued stocks. On June 5, Stifel maintained a Buy rating on EQR with a ...

Churchill Downs Incorporated (NASDAQ:CHDN) ranks among the 30 stocks expected to beat the market by 20 percentage points this ...

Vistagen Therapeutics, Inc. (NASDAQ:VTGN) is among the best growth stocks to invest in for the next 5 years. Analysts at Stifel reiterated their Buy rating on Vistagen Therapeutics, Inc. (NASDAQ ...

Stifel notes that while the U.S. market may improve, Alcon’s international IOL business could face challenges in 2026 due to intensifying competition in overseas markets.